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Ayurveda is one of the complementary and alternative systems of medicine requiring generation of high
quality evidence for rational practice. Evidence can be generated from study designs and the present
study is an attempt to critically assess the registered studies in the ﬁeld of Ayurveda from clinical trial
registry of India. We found low number of trials conducted with more focus required on the quality of
these studies to contribute to high quality evidence.
© 2016 Transdisciplinary University, Bangalore and World Ayurveda Foundation. Publishing Services by
Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).1. Introduction
Clinical trials form the main source of evidence-based medicine
(EBM) and thereby forming the backbone of clinical practice. Evi-
dence-Based Practice (EBP) has become the treatment of choice and
is a combination of research, clinical experience and patient pref-
erences. The most common deﬁnition of EBP is from Dr. David
Sackett “EBP is the conscientious, explicit and judicious use of
current best evidence in making decisions about the care of the
individual patient. It means integrating individual clinical expertise
with the best available external clinical evidence from systematic
research.” [1] Traditional, theoretical, anecdotal reasoning has to be
replaced by high quality evidence which becomes possible only by
publication of high quality research data [2]. The strength of
recommendation depends on the type of evidence generated and
generally it forms a pyramid. Usually, the least in the cadre is the
expert's opinion followed by observational study, randomized
controlled trial and ﬁnally at the top of the pyramid, meta-analysis
[3]. A recent study conducted on clinical trials in the ﬁeld of
dentistry reported poor publication details of the research being
conducted. [Unpublished manuscript] EBP in the ancient era used
anecdotes which were transmitted by means of stories. This in the
current scenario is in the form of publications. Some of knowledge
regarding traditional medicines was codiﬁed and available in forman).
ary University, Bangalore.
lore and World Ayurveda Foundat
es/by-nc-nd/4.0/).of books like-Ayurveda, Siddha, Unani, Tibetan medicine, Chinese
traditional medicine Acupuncture and Korean traditional medicine
which was based on evidence that was not robust in scientiﬁc
methodology [4]. EBP in Ayurveda is not being considered because
of the lack of good quality clinical trials and enough publications
[5]. Bridging EBP and Ayurveda is a task because this empowers
researchers and clinicians' decision making. Considering this the
present study was conducted to identify the scope of EBP in Ay-
urveda and obtain a holistic view on the methodological charac-
teristics of the studies carried out in this ﬁeld of medicine.2. Methodology
The study was conducted on trials that were registered and
available as public domain in Clinical Trial Registry of India [CTRI
(www.ctri.nic.in)] and so was waived from obtaining ethics com-
mittee approval. All ﬁlters with regard to phase, type, recruitment
status and place of trial were eliminated. Search was madewith the
key word “Ayurveda” and the following information was collected
for each of the obtained clinical trials: number of centres (single/
multicentre), type of institution (government/private/combined),
study design (randomized/single/double-blinded), type of study
(observational/interventional), type of participants (healthy/pa-
tients), type of health condition, phase of clinical trial (Phase 1/2/3/
4), publication details (published/not published), postgraduate
thesis or not, nature of sponsors (academic/commercial), prospec-
tive or retrospective registration of clinical trials andion. Publishing Services by Elsevier B.V. This is an open access article under the CC
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concealment of allocation)]. Descriptive statistics were used to
analyze these parameters. Trend analysis was done for all these
parameters for the entire duration. Chi-square for trendanalysiswas
employed to assess the trend difference between types of sponsors
(academic/commercial). P  0.05 was considered signiﬁcant.
3. Results
3.1. Number of clinical trials
The search yielded a total of 208 trials registered in Ayurveda
over the speciﬁed time period (3-2010; 35-2011; 52-2012; 71-2013,
35-2014; 12-2015). Of this 167/208 (80.2%) were single centered
and only 41/208 (19.7%) were multi-centered. A total of 13/208
(6.25%) of the registered studies were sponsored by the pharma-
ceutical companies and no signiﬁcant trend (P ¼ 0.6) was observed
in this category over the years.
3.2. Characteristics of registered clinical trials
Nearly two-thirds (130/208, 62.5%) of the studies were ran-
domized controlled designs while 2/208 (0.96%) were non-ran-
domized interventional trials. Only 9/208 (4.3%) were observational
and reported in the year 2010 and 2011. More incline towards
interventional trials was reported over the years. Considering the
study design, only 21/130 (16.2%) were double blinded, 18/130
(13.8%) were single blinded and 8/130 (6.2%) were triple blinded.
Despite this 70/208 (33.6%) of the randomized interventional trials
did not describe blinding technique and 43.75% (91/208) of the
studies were open labeled. Majority of clinical trials were con-
ducted on patients 196/208 (94.2%) and the rest were on healthy
volunteers. Diabetes [17/208 (8.1%)], bronchial asthma [12/208
(5.7%)], Anemia [8/208 (3.8%)] and hypertension [7/208 (3.3%)]
were the most common conditions over which trials were con-
ducted. Most of the trials were done in an academic set up [195/208
(93.7%)] while the rest in private set up. The phase of the trial was
unclear in [37/208 (17.7%)] of the trials. Of the remaining, 3/208
(1.4%) belonged to Phase I, 87/208 (41.8%) in Phase II, 13/208 (6.25%)
in Phase III, 11/208 (5.2%) in Phase IV. 21/208 (10.1%) trials were
unclear whether it belonged to Phase I or II, 31/208 (14.9%) in Phase
II or III, and 2/208 (0.96%) in Phase III or IV. A total of 168/208
(80.8%) were registered retrospectively.
3.3. Methodological quality and publication of the registered
clinical trials
A total of 130/208 (62.5%) studies were conducted using the
randomization design. Regarding the method of randomization
sequence generation, 43/130 (33.1%) followed coin toss, lottery and
throw of dice, 60/130 (46.1%) used computer generated list, 12/130
(9.2%) used random number table and 1/130 (0.7%) used stratiﬁed
block randomization and 2/130 (1.5%) followed adaptive randomi-
zation. A total of 4/130 (3.1%) mentioned that randomization was
not applicable when it was actually applicable. The various
methods of concealment of allocation used were alternation [1/208
(0.4%)], case record number [6/208 (2.9%)], centralized [3/208
(1.4%)], on-site computer system [3/208 (1.4%)], pharmacy
controlled [3/208 (1.4%)] and pre-numbered or coded [9/208
(4.2%)]. A total of 94/208 (45.1%) of the studies did not use any form
of allocation concealment. Out of the 52/208 (25%) of the
completed trials only 1 was published which needs to be high-
lighted. A total of 195/208 (93.7%) were done for academic purposes
and 161/208 (77.4%) were post-graduate thesis studies of which
only one had been reportedly published.4. Discussion
This study aimed at identifying the status of clinical trials being
conducted in the ﬁeld of Ayurveda. This study also emphasizes the
signiﬁcance of documenting these trials in the form of publications
which would end up in improving the quality of treatment pro-
vided in the form of EBP. Although majority of the trials were
randomized, double blinded and single centered, still not all of
these have mentioned the nature of randomization and allocation
concealment. Majority of the studies were conducted for academic
purposes. Considerable numbers of trials were conducted on pa-
tients with unclear phase and rarely were they published. Few trials
inadequately reported the method of randomization and allocation
concealment.
Ayurveda has its roots in Srilanka and India 3500 years ago and
is one of the commonly practiced complementary and alternate
systems of medicine (CAM). The use of Ayurvedic medicine has
increased tremendously worldwide due to cost and consumer
preference. Despite Asian origin, a recent study in the United States
of America has shown nearly 59% of the study population used
Ayurveda and almost all were aware of Ayurveda [6]. Patients with
chronic pain, cancer and infection by human immunodeﬁciency
virus were estimated to use Ayurveda more commonly [7]. As
deﬁned, EBM is all about analyzing and publishing the data which
would help in ﬁnal decision making [1]. Despite a widespread
acceptance of EBP, there is a potential for the emergence of various
types of biases that mainly includes limited patient involvement in
the trials [8]. The practice of evidence-based medicine requires
integrating individual clinical experience with the best available
external clinical evidence [9]. The four main aspects of deciding
treatment in Ayurveda include “tradition (inherited from ances-
tors), conventional (from other examples), belief (with the formula
of dravya, guna, virya and karma)” and EBM, a combination of all
these parameters to personalize the treatment [10]. The complex-
ities involved in carrying out trials in Ayurveda are well-known
such as treatment plan based on prakriti; difﬁculty in using blind-
ing technique due to the odor and taste of Ayurveda medicine;
holistic approach such as modiﬁcation of behavior and dietary re-
gimes associated with Ayurveda treatment and the differential
assessment of outcomes based on doshas; lack of standardization of
Ayurveda medicines and variation in the method and mode of drug
administration [11]. Furthermore, there is limited support from
various organizations in terms of granting funds to conduct trials in
Ayurveda [12]. Despite these limitations, generation of good quality
evidence pertaining to Ayurveda is essential for rational use. Ini-
tiatives such as consolidated standards of reporting trials in herbal
interventions can be utilized by the investigators/researchers while
drafting protocol and registering studies that will aid them to
perform these tasks credibly [13]. More than 400,000 registered
Ayurvedic physicians at more than 250 government-accredited
universities or colleges form a major resource for carrying out
clinical trials related to the ﬁeld [14]. But, a recent review of 225
original studies published in Indian Ayurveda journals concluded a
non-satisfactory diagnoses and inconclusive outcomes being used
in nearly 90% of the published studies [15]. Experts suggest that
Ayurvedic medicine needs more rigorous scientiﬁc research for
evaluating safety, quality and efﬁcacy to be acceptable to the sci-
entiﬁc communities [16,17]. Few other researchers in the ﬁeld of
Ayurveda even suggest that instead of hierarchical approach, a
circular approach to keep a balance between internal and external
validity is better especially for trials evaluating CAM [18]. A similar
analysis in the World Health Organization e International Clinical
Trial Registry Platform lead to similar results in Ayurveda [19]. Not
only in Ayurveda, similar ﬁndings in the study methodology and
characteristics have been reported in dentistry as well [20]. CTRI is
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research conducted in India. Interventional studies related to
various medical and para-medical ﬁelds such as allopathy,
dentistry, complementary and alternative systems of medicine and
pharmacy carried out in India have to be registered in CTRI. Hence,
for novice researchers, an update on the various aspects of Ayur-
vedic clinical studies such as study design, nature of intervention,
details of funding and the institutions/investigators carrying out
research will be available to ﬁll their knowledge gap, avoid dupli-
cation of research that is being carried out in other centers and
improving the research transparency.
5. Conclusions
We found that only few clinical trials are being carried out in the
ﬁeld of Ayurveda in India and more focus has to be on the quality of
studies to generate high quality evidence based on which ﬁrm
recommendations shall be made.
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